Our Portfolio

CYRUS is a spin-off of the NSCR Demokritos, established by a team of scientists, active in the market of hydrogen energy applications for over 20 years. CYRUS offers a noise free hydrogen compression system based on metal hydrides using only water as the cooling / heating medium achieving hydrogen pressures > 350 bar.

CYRUS’ Metal Hydride Compressor has unique advantages, including no use of CRMs, and use of low – grade thermal energy resulting in very low O&M costs. Its main target market is Hydrogen Refueling Stations (HRS) for vehicles.

EnzyQuest is the first company operating in the field of enzymatic biotechnology in Southeast Europe. It has already developed a portfolio of 70 products and currently focuses on the identification and discovery of enzymes with novel properties and pioneering applications from Extremophiles, i.e microorganisms that are able to grow optimally under very low or very high temperature, extreme pH, and high salinity.

EnzyQuest has developed a wide distribution network in Greece and Cyprus, which is currently expanding to Europe and Asia. 

FoodOxys is a spin-off of the University of Thessaly. Capitalizing on more than 15 years of world-class research on functional food and metabolic control of oxidative stress, the company aims to create and appropriate value from the global trend of self-directed care, by focusing on food as a means of wellness to prevent disease, improve health and enhance quality of life.

FoodOxys has developed a patented portable device for the assessment of the levels of glutathione in blood. A single drop of blood of the person tested is required for the testing, while results are delivered in less than 30 minutes; nutrition plans are then generated based on the individual’s antioxidants’ level to achieve better health and wellness. Other services of the company include analyses of the antioxidants in foods to assess the products’ quality level.

K-Invent is actively involved in the fields of physical rehabilitation and sports biomechanics producing innovative measuring and training devices for the facilitation of every day and athletic movements. Comprising of a group of scientists who combine strong technological skills and scientific knowledge, K-Invent produces solutions that address any challenge of professionals in sports and rehabilitation.

K-Force, K-Invent’s complete product line, is an integrated system of connected devices accessible through a single app that tracks force, balance and human movement and simplifies evidence-based reporting. It combines IoT technology with the latest trends in rehabilitation and has already been adopted by professionals in 20 countries.

Nanoplasmas is a spin-out company of NCSR Demokritos, with expertise in micro-nanotechnology and surface engineering, preparing high-end consumables for health, food safety, agricultural and environmental applications.

Its patented technology has been incorporated into microfluidic devices creating lab-on-chip diagnostics and lately focused on the development of a novel bacteria capture lab-on-chip kit for the detection of Legionella pheumophila bacteria in water. Nanoplasmas has several other products in the pipeline based on its innovative plasma nanotexturing technology.

PLiN Nanotechnology S.A. is a technology driven spin-off company of the Aristotle University of Thessaloniki (AUTH), commercializing on decades of R&D. Having access to the latest research and knowledge available, PLiN’s award-winning team has developed a strong portfolio of high-quality nanomaterials for several industry sectors.

PLiN’s focus has lately been directed towards a line of para-pharmaceuticals, debuting in a brand of nano-enhanced pet products, launched under the trademark NanoSanitasTM. Inspired by nature, NanoSanitasTM silver-based technology promotes wound healing and relieves infections. NanoSanitasTM products are already exported to 9 countries.

QCELL is a spin-off of the Technical University of Crete, Chania, which has developed and patented game-changing innovations in imaging science and technology. The company introduces a new generation of electronic imaging devices, offering video rate hyperspectral imaging.

QCELL’s products are intended to change medical practices worldwide by allowing for the clinical implementation of the “optical biopsy” and “see and treat” approaches, thus contributing to both cancer prevention and to health-care cost reduction.